Schedule 13G ownership disclosure
Vanda Pharmaceuticals Inc
Security class unavailable · CUSIP: 921659108
Event date: 2015-03-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-022307
- Form type
- SC 13G
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Apr 10, 2015
- Reporting period
- Mar 10, 2015
- Description
- Schedule 13G beneficial ownership